CVS Market Analysis

Wall Street coverage

third-party context

Wall Street coverage

$113.50median target· current $104.44 (+8.7%)28 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

News & Sentiment

24 articles · sorted by date
Page 1 of 2 · 24 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Fundamentals

Updated daily after market close
P/E ratio45.80Forward 14.16
EPS (TTM)$2.2863.1% YoY
Profit margin0.7%HEALTHCARE
Market cap$133.25BLarge cap

Valuation

Forward P/E
14.16
PEG ratio
0.29
P/B
1.72
P/S (TTM)
0.33
EV/EBITDA
17.95

Profitability & growth

ROE (TTM)
3.8%
Operating margin
4.1%
Revenue growth YoY
6.1%
Dividend yield
2.5%
Beta
0.60
Last earnings
May 6, 2026 · Estimate $2.21 · Reported $2.57
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About CVS Health Corp

Company profile

CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.

Classification

Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
ONE CVS DRIVE, WOONSOCKET, RI
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$133.25B
Shares outstanding$1.28B
52W high$110.00
52W low$59.46

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer